Adipose-derived cell processing unit
CA 2849201 A1 · Owner: Macropore Biosurgery, Inc. · Inventors: Hedrick, Marc H.; Fraser, John
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Cells present in processed lipoaspirate tissue are used to treat patients. Methods of treating , patients include processing adipose tissue to deliver a concentrated amount of stem cells obtained , from the adipose tissue to a patient. The methods may be practiced in a closed system so that the , stem cells are not exposed to an external environment prior to being administered to a patient. , Compositions that are administered to a patient include a mixture of adipose tissue and stem cells , so that the composition has a higher concentration of stem cells than when the adipose tissue was , removed from the patient.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 9, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 9, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 9, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.